Skip to content

‘Test-to-treat’ COVID-19 site opens at MSP

People who test positive for COVID-19 at the MSP Airport (MSP) testing site can now be evaluated onsite by a medical professional and get a prescription for the antiviral drug Paxlovid if deemed appropriate.

The "test-to-treat" site opened at MSP on Thursday (June 23) on Level 2 of the Blue Ramp at Terminal 1 and is open from 7 a.m. to 7 p.m. The services are free to Minnesotans. Walk-ins are accepted but appointments are recommended at

Only patients deemed high risk by a clinician will receive a prescription for Paxlovid, which has received emergency approval from the FDA to treat COVID-19.

The test-to-treat site at MSP is one of several opened throughout the state by the Minnesota Department of Health and the federal government.   

"COVID-19 medication is a very important tool in our toolbox to help prevent severe disease and keep people out of the hospital, and test-to-treat makes it easier for eligible Minnesotans to receive these medicines," said Minnesota Commissioner of Health Jan Malcolm. "Minnesotans who feel ill and are at high-risk of severe COVID-19 should visit a test-to-treat site or speak to their health care provider to see if medication is right for them. We are grateful to our federal partners and testing site hosts who are helping us make these resources more accessible."

Minnesotans seeking medication at community test-to-treat sites should be prepared to provide details of their medical history, particularly their current medications, to the on-site clinician.

To make room for the medical professionals, the MSP Community Vaccination operation will close effective Thursday, June 30. Minnesotans can find other vaccination locations at

Related information

Minnesota expands test-to-treat options and adjusts COVID-19 community testing network – Minnesota Department of Health press release

COVID-19 Testing Sites at MSP Airport –